These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16389756)

  • 1. [Glucocorticoids and their effect on dendritic cell function].
    Rozková D; Horváth R; Bartůnková J; Spísek R
    Cas Lek Cesk; 2005; 144(12):825-31; discussion 832. PubMed ID: 16389756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors.
    Rozkova D; Horvath R; Bartunkova J; Spisek R
    Clin Immunol; 2006 Sep; 120(3):260-71. PubMed ID: 16765091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells.
    Cicinnati VR; Hou J; Lindemann M; Horn PA; Sotiropoulos GC; Paul A; Gerken G; Beckebaum S
    Transplantation; 2009 Aug; 88(4):504-13. PubMed ID: 19696633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of immunosuppressive drugs on dendritic cells.
    Abe M; Thomson AW
    Transpl Immunol; 2003; 11(3-4):357-65. PubMed ID: 12967788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies.
    Franchimont D
    Ann N Y Acad Sci; 2004 Jun; 1024():124-37. PubMed ID: 15265777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.
    van Kooten C; Stax AS; Woltman AM; Gelderman KA
    Handb Exp Pharmacol; 2009; (188):233-49. PubMed ID: 19031029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic dendritic cells: the ins and outs of outcome.
    Xiao BG; Huang YM; Link H
    J Immunother; 2006; 29(5):465-71. PubMed ID: 16971802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Flt-3-ligand-mobilized dendritic cells require additional activation to drive effective immune responses.
    Diener KR; Moldenhauer LM; Lyons AB; Brown MP; Hayball JD
    Exp Hematol; 2008 Jan; 36(1):51-60. PubMed ID: 17949888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum group elements enhance the allergic immune response by acting on dendritic cells.
    Paolucci C; Ponti J; Fabbri MV; Breda D; Sabbioni E; Burastero SE
    Int Arch Allergy Immunol; 2007; 143(3):225-36. PubMed ID: 17290149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells.
    Cools N; Ponsaerts P; Van Tendeloo VF; Berneman ZN
    J Leukoc Biol; 2007 Dec; 82(6):1365-74. PubMed ID: 17711977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of alloimmune responses by dendritic cell subsets.
    Lonial S; Torre C; David E; Harris W; Arellano M; Waller EK
    Exp Hematol; 2008 Oct; 36(10):1309-17. PubMed ID: 18620796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance?
    Lebre MC; Tak PP
    Hum Immunol; 2009 May; 70(5):321-4. PubMed ID: 19236901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance?
    Steinbrink K; Mahnke K; Grabbe S; Enk AH; Jonuleit H
    Hum Immunol; 2009 May; 70(5):289-93. PubMed ID: 19217922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-dependent selection of microbial antigens for presentation by dendritic cells.
    Blander JM; Medzhitov R
    Nature; 2006 Apr; 440(7085):808-12. PubMed ID: 16489357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of immune inhibitory dendritic cells and CD4+T regulatory cells inducing by TGF-beta.
    Abediankenari S; Ghasemi M
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):25-30. PubMed ID: 19279356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs.
    Hackstein H; Thomson AW
    Nat Rev Immunol; 2004 Jan; 4(1):24-34. PubMed ID: 14704765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.